Trials / Recruiting
RecruitingNCT05896826
Magnetocardiography in the Accurate Identification of Myocardial Infarction
Ultra-sensitive Magnetocardiography in the Accurate Identification of Myocardial Infarction
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,841 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial infarction. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect myocardial infarction. Myocardial infarction are diagnosed by electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography). Myocardial infarction is also quantified by cardiac magnetic resonance or single-photon-emission tomography. Healthy volunteers and chest pain patients who will receive electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography) examination will be enrolled in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetometer | inspection equipment for magnetocardiography |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-10-31
- Completion
- 2026-12-01
- First posted
- 2023-06-09
- Last updated
- 2025-10-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05896826. Inclusion in this directory is not an endorsement.